Echinaforce Protect Tablets

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Echinacea purpurea, Quantity: 380 mg (Equivalent: Echinacea purpurea, Qty 150 mg); Echinacea purpurea, Quantity: 20 mg (Equivalent: Echinacea purpurea, Qty 7.7 mg)

Verfügbar ab:

A Vogel Australia Pty Ltd

INN (Internationale Bezeichnung):

Echinacea purpurea

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: magnesium stearate; pregelatinised potato starch; lactose monohydrate

Verabreichungsweg:

Oral

Anwendungsgebiete:

Decrease/reduce ear irritation/inflammation ; Helps enhance/promote/increase vitality ; Relieve weariness/tiredness/fatigue/feeling of weakness ; Decrease/reduce/relieve watery eyes/excessive lacrimation ; Helps enhance/promote general health and wellbeing ; Enhance/improve/promote immune defence/immunity ; Helps enhance/improve/promote immune system function ; Helps stimulate a healthy immune system response ; Decrease/reduce/relieve muscle pain/ache/soreness ; Enhance/promote body adaptation to stress ; Decrease/reduce/relieve headache symptoms ; Unblock/clear nasal passages ; Decrease/reduce/relieve common cold duration ; Decrease/reduce/relieve symptoms of common colds and flu ; Decrease/reduce/relieve mild upper respiratory tract congestion ; Decrease/reduce/relieve sneezing ; Decrease/reduce/relieve chills associated with common cold ; Relieve symptoms of mild upper respiratory tract infections ; Helps reduce occurrence of symptoms of upper respiratory tract infections ; Decrease/reduce/relieve cough ; Relieve runny/dripping nose ; Relieve symptoms of sore throat/pharyngitis

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-05-05